Literature DB >> 19914247

Opposing and uncoupling effects of mTOR and S6K1 in the regulation of endothelial tissue factor expression.

Xiu-Fen Ming1, Angana Gupta Rajapakse, João Miguel Carvas, Jean Ruffieux, Zhihong Yang.   

Abstract

Rapamycin has been reported to enhance tissue factor (TF) expression. The present study investigated roles of mammalian target of rapamycin (mTOR) and its downstream S6K1 in this process. We showed here that, consistent with rapamycin, knocking-down mTOR enhanced thrombin-induced TF mRNA and protein levels, whereas silencing S6K1 mitigated up-regulation of TF protein but not TF mRNA level. The enhanced TF protein level upon mTOR-silencing was further augmented by over-expression of a constitutively active S6K1 mutant and reduced by blocking RhoA, p38(mapk) or NF-kappaB. The results reveal an opposing and uncoupling effect of mTOR and S6K1 in regulating TF expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19914247     DOI: 10.1016/j.febslet.2009.11.030

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

Review 1.  Mammalian target of rapamycin signaling in cardiac physiology and disease.

Authors:  Sebastiano Sciarretta; Massimo Volpe; Junichi Sadoshima
Journal:  Circ Res       Date:  2014-01-31       Impact factor: 17.367

2.  mTORC2 facilitates endothelial cell senescence by suppressing Nrf2 expression via the Akt/GSK-3β/C/EBPα signaling pathway.

Authors:  Han-Wei Yang; Hui-Ling Hong; Wen-Wei Luo; Chun-Mei Dai; Xin-Yi Chen; Lu-Ping Wang; Qian Li; Zi-Qing Li; Pei-Qing Liu; Zhuo-Ming Li
Journal:  Acta Pharmacol Sin       Date:  2018-07-10       Impact factor: 6.150

3.  Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrol.

Authors:  Angana G Rajapakse; Gautham Yepuri; João M Carvas; Sokrates Stein; Christian M Matter; Isabelle Scerri; Jean Ruffieux; Jean-Pierre Montani; Xiu-Fen Ming; Zhihong Yang
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

4.  Perspectives of Targeting mTORC1-S6K1 in Cardiovascular Aging.

Authors:  Xiu-Fen Ming; Jean-Pierre Montani; Zhihong Yang
Journal:  Front Physiol       Date:  2012-01-25       Impact factor: 4.566

5.  Arginase II Promotes Macrophage Inflammatory Responses Through Mitochondrial Reactive Oxygen Species, Contributing to Insulin Resistance and Atherogenesis.

Authors:  Xiu-Fen Ming; Angana G Rajapakse; Gautham Yepuri; Yuyan Xiong; João M Carvas; Jean Ruffieux; Isabelle Scerri; Zongsong Wu; Katja Popp; Jianhui Li; Claudio Sartori; Urs Scherrer; Brenda R Kwak; Jean-Pierre Montani; Zhihong Yang
Journal:  J Am Heart Assoc       Date:  2012-08-24       Impact factor: 5.501

6.  Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation.

Authors:  Zhihong Yang; Xiu-Fen Ming
Journal:  Front Immunol       Date:  2013-06-12       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.